1
|
Matsuki N, Suzuki E, Mitsuhashi T, Subramanian SV, Takao S, Yorifuji T. Complementary and Alternative Medicine Use, Cancer Screening, and Medical Checkups in Japan from 2001 to 2013: A Repeated Cross-Sectional Study. JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE 2024; 30:47-56. [PMID: 37379489 DOI: 10.1089/jicm.2023.0077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/30/2023]
Abstract
Introduction: The association between complementary and alternative medicine (CAM) use and other health-related behaviors is an important issue. A previous study reported that complementary medicine use is related to greater use of cancer screening, whereas alternative medicine use is related to lower use of cancer screening. Given the sparse evidence from Japan, we aimed to examine the association of CAM use with cancer screening and medical checkups. We used a repeated cross-sectional survey of a nationally representative sample of Japanese people and conducted age-period-cohort analysis. Methods: The study population was 68,217 of 83,827 individuals observed from 2001 to 2013 who received cancer screening. CAM users were defined as individuals who received acupuncture, moxibustion, anma/massage/shiatsu, or judo therapy for their most worrisome symptom. The outcomes of interest were receiving stomach, lung, colorectal, uterine, and breast cancer screenings and medical checkups. Using crossclassified multilevel logistic regression models, we estimated odds ratios (ORs) and 95% credible intervals (CIs) for cancer screening and medical checkups. Results: For CAM users of complementary medicine, the adjusted ORs for stomach, lung, and colorectal cancer screening were 1.40 (95% CI: 1.35-1.44), 1.37 (95% CI: 1.34-1.40), and 1.52 (95% CI: 1.49-1.54), respectively. We found similar results for uterine and breast cancer screening, and medical checkups. Conclusions: Irrespective of whether they use CAM, CAM users in Japan tend to receive a variety of cancer screenings and medical checkups.
Collapse
Affiliation(s)
- Nobuyoshi Matsuki
- Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
| | - Etsuji Suzuki
- Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Toshiharu Mitsuhashi
- Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan
| | - S V Subramanian
- Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- Harvard Center for Population and Development Studies, Cambridge, MA, USA
| | - Soshi Takao
- Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
| | - Takashi Yorifuji
- Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
| |
Collapse
|
2
|
Voiß P, Höxtermann MD, Dobos G, Cramer H. Complementary Medicine Use and Uptake of Cancer Screening Among US Adults: A Nationally Representative Cross-Sectional Survey. Integr Cancer Ther 2021; 19:1534735420943286. [PMID: 32697118 PMCID: PMC7376296 DOI: 10.1177/1534735420943286] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Background: Cancer screenings can considerably reduce cancer
mortality. There is limited information on the association between complementary
medicine use and adherence to recommended cancer screenings. In this study, the
potential associations between uptake of cancer screening and consultations with
complementary medicine practitioners or mind-body medicine use are examined.
Methods: This is a cross-sectional analysis of the 2017
National Health Interview Survey of a population-based sample (n = 26 742;
response rate = 80.7%). Age- and sex-related risk groups for breast cancer
(women 45 years and older), cervical cancer (women 21 years and older), and
colorectal cancer (45 to 85 years) were analyzed in 2018. Prevalence of
complementary medicine use in the past 12 months as well as prevalence of cancer
screening uptake in the past 12 months were calculated. Results: At
least one complementary medicine approach was used by 32.4% of participants.
Controlling for sociodemographic and clinical variables, individuals who
consulted a chiropractor or naturopath or who used mind-body medicine approaches
were more likely to take up Pap smear test (odds ratio = 1.20-1.35), mammography
(odds ratio = 1.22-1.38), and/or colorectal cancer screening (odds ratio =
1.18-1.37). Those consulting a homeopath were more likely to take up Pap smear
test (odds ratio = 1.33). No association was found between consultations of
practitioners of chelation therapy or traditional medicine and cancer screening
uptake. Conclusion: Complementary medicine use seems to be
associated with a better adherence to cancer screening. Individuals who
consulted a chiropractor or naturopath or who used mind-body medicine approaches
were more likely to take up the recommended screening.
Collapse
Affiliation(s)
- Petra Voiß
- Department of Internal and Integrative
Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen,
Essen, Germany
| | - Melanie Désirée Höxtermann
- Department of Internal and Integrative
Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen,
Essen, Germany
| | - Gustav Dobos
- Department of Internal and Integrative
Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen,
Essen, Germany
| | - Holger Cramer
- Department of Internal and Integrative
Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen,
Essen, Germany
- Holger Cramer, Department of Internal and
Integrative Medicine, Evang. Kliniken Essen-Mitte, Faculty of Medicine,
University of Duisburg-Essen, Am Deimelsberg 34a, Essen 45276, Germany.
| |
Collapse
|
3
|
Cumin Prevents 17β-Estradiol-Associated Breast Cancer in ACI Rats. Int J Mol Sci 2021; 22:ijms22126194. [PMID: 34201250 PMCID: PMC8228322 DOI: 10.3390/ijms22126194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Revised: 05/28/2021] [Accepted: 06/04/2021] [Indexed: 11/16/2022] Open
Abstract
Breast cancer (BC) is a leading cause of cancer deaths in women in less developed countries and the second leading cause of cancer death in women in the U.S. In this study, we report the inhibition of E2-mediated mammary tumorigenesis by Cuminum cyminum (cumin) administered via the diet as cumin powder, as well as dried ethanolic extract. Groups of female ACI rats were given either an AIN-93M diet or a diet supplemented with cumin powder (5% and 7.5%, w/w) or dried ethanolic cumin extract (1%, w/w), and then challenged with subcutaneous E2 silastic implants (1.2 cm; 9 mg). The first appearance of a palpable mammary tumor was significantly delayed by both the cumin powder and extract. At the end of the study, the tumor incidence was 96% in the control group, whereas only 55% and 45% animals had palpable tumors in the cumin powder and extract groups, respectively. Significant reductions in tumor volume (660 ± 122 vs. 138 ± 49 and 75 ± 46 mm3) and tumor multiplicity (4.21 ± 0.43 vs. 1.16 ± 0.26 and 0.9 ± 0.29 tumors/animal) were also observed by the cumin powder and cumin extract groups, respectively. The cumin powder diet intervention dose- and time-dependently offset E2-related pituitary growth, and reduced the levels of circulating prolactin and the levels of PCNA in the mammary tissues. Mechanistically, the cumin powder diet resulted in a significant reversal of E2-associated modulation in ERα, CYP1A1 and CYP1B1. Further, the cumin powder diet reversed the expression levels of miRNAs (miR-182, miR-375, miR-127 and miR-206) that were highly modulated by E2 treatment. We analyzed the composition of the extract by GC/MS and established cymene and cuminaldehyde as major components, and further detected no signs of gross or systemic toxicity. Thus, cumin bioactives can significantly delay and prevent E2-mediated mammary tumorigenesis in a safe and effective manner, and warrant continued efforts to develop these clinically translatable spice bioactives as chemopreventives and therapeutics against BC.
Collapse
|
4
|
Frawley JE, McIntyre E, Sibbritt D, Wardle J, Schloss J, Lauche R, Adams J. Associations Between Cancer Screening Behavior and Complementary Medicine Use: Results of a National Cross-Sectional Survey of 9151 Australian Women. Integr Cancer Ther 2018; 17:979-985. [PMID: 29896978 PMCID: PMC6142111 DOI: 10.1177/1534735418781728] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Introduction: Complementary medicine (CM) use has been found to
influence the uptake of conventional cancer treatment. This study examines
associations between CM use and cancer screening rates. Methods:
Women aged 62 to 67 years from the Australian Longitudinal Study on Women’s
Health were surveyed regarding their use of cancer screening initiatives.
Associations between cancer screening behavior and visits to CM practitioners
were analyzed. Results: Of the 9151 women, 9049 (98.9%) completed
questions about cancer screening. A total of 65.1% of women had received a
clinical skin examination, 54.3% colorectal cancer screening, 56.2% Pap test
(within past 2 years), 83.3% mammogram (within past 2 years), 55.8% clinical
breast examination, and 55.8% had conducted breast self-examination. Women who
had consulted a massage therapist were more likely to undergo clinical skin
examination (P = .002), clinical breast examination
(P = .018), and mammogram (P = .001).
Women who had consulted a chiropractor were more likely to undergo a clinical
skin examination (P = .001), colorectal cancer screening
(P = .020), and mammogram (P = .011).
Women who had consulted an acupuncturist were more likely to undergo colorectal
cancer screening (P = .019), and those who consulted with an
osteopath were more liable to have a Pap test (P = .049).
Conclusion: Women who visit CM practitioners are more likely to
participate in cancer screening initiatives. Research is required to understand
the current and potential role that CM practitioners (can) have as public health
advocates, recommending preventative health measures such as cancer screening.
Such an examination will help ensure optimal screening utilization and
effective, timely care for all cancer patients.
Collapse
Affiliation(s)
| | - Erica McIntyre
- 1 University of Technology Sydney, Sydney, New South Wales, Australia
| | - David Sibbritt
- 1 University of Technology Sydney, Sydney, New South Wales, Australia
| | - Jon Wardle
- 1 University of Technology Sydney, Sydney, New South Wales, Australia
| | - Janet Schloss
- 2 Endeavour College of Natural Health, Brisbane, Queensland, Australia
| | - Romy Lauche
- 1 University of Technology Sydney, Sydney, New South Wales, Australia
| | - Jon Adams
- 1 University of Technology Sydney, Sydney, New South Wales, Australia
| |
Collapse
|
5
|
Roumeliotis GA, Dostaler G, Boyd KU. Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer. Plast Surg (Oakv) 2017; 25:275-283. [PMID: 29619352 DOI: 10.1177/2292550317716126] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Background The use of complementary and alternative medicines (CAMs) is common among women being treated for breast cancer. A recent mortality associated with CAM at our center precipitated a systematic review of the Cochrane, EMBASE, and PubMed databases to identify English manuscripts including "CAM" and "breast cancer." Methods Papers included for review were selected based on predefined inclusion and exclusion criteria. The primary outcome was the use of CAM by women with breast cancer. Secondary outcomes included timing of use along disease trajectory, attitudes toward CAM by allopathic practitioners, and patient disclosure of CAM use to treating allopathic physicians. Results Of 701 titles identified by the search strategy, 36 met the inclusion criteria. The weighted average proportion of women with breast cancer who use CAM was 40% (standard deviation: 18%). The diagnosis of breast cancer also prompts the initiation or increase of CAM use. However, up to 84% of patients do not disclose the use of CAM to their allopathic practitioners. Conclusions Although CAM is often dismissed as a harmless addition to allopathic therapy, significant complications and interactions can occur. Our review and the dramatic case example provided highlight the need for physicians to educate themselves regarding CAM and to engage with their patients regarding its use.
Collapse
Affiliation(s)
- Grayson A Roumeliotis
- Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada
| | | | - Kirsty U Boyd
- Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada
| |
Collapse
|
6
|
Chemoprevention of Rat Mammary Carcinogenesis by Apiaceae Spices. Int J Mol Sci 2017; 18:ijms18020425. [PMID: 28212313 PMCID: PMC5343959 DOI: 10.3390/ijms18020425] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Revised: 01/17/2017] [Accepted: 02/08/2017] [Indexed: 02/07/2023] Open
Abstract
Scientific evidence suggests that many herbs and spices have medicinal properties that alleviate symptoms or prevent disease. In this study, we examined the chemopreventive effects of the Apiaceae spices, anise, caraway, and celery seeds against 17β-estrogen (E2)-mediated mammary tumorigenesis in an ACI (August-Copenhagen Irish) rat model. Female ACI rats were given either control diet (AIN 93M) or diet supplemented with 7.5% (w/w) of anise, caraway, or celery seed powder. Two weeks later, one half of the animals in each group received subcutaneous silastic implants of E2. Diet intake and body weight were recorded weekly, and animals were euthanized after 3 and 12 weeks. E2-treatment showed significantly (2.1- and 3.4-fold) enhanced growth of pituitary gland at 3 and 12 weeks, respectively. All test spices significantly offset the pituitary growth by 12 weeks, except celery which was effective as early as three weeks. Immunohistochemical analysis for proliferative cell nuclear antigen (PCNA) in mammary tissues showed significant reduction in E2-mediated mammary cell proliferation. Test spices reduced the circulating levels of both E2 and prolactin at three weeks. This protection was more pronounced at 12 weeks, with celery eliciting the highest effect. RT-PCR and western blot analysis were performed to determine the potential molecular targets of the spices. Anise and caraway diets significantly offset estrogen-mediated overexpression of both cyclin D1 and estrogen receptor α (ERα). The effect of anise was modest. Likewise, expression of CYP1B1 and CYP1A1 was inhibited by all test spices. Based on short-term molecular markers, caraway was selected over other spices based on its enhanced effect on estrogen-associated pathway. Therefore, a tumor-end point study in ACI rats was conducted with dietary caraway. Tumor palpation from 12 weeks onwards revealed tumor latency of 29 days in caraway-treated animals compared with first tumor appearance at 92 days in control group. At the end of the study (25 weeks), the tumor incidence was 96% in the control group compared with only 70% in the caraway group. A significant reduction in tumor volume (661 ± 123 vs. 313 ± 81 mm³) and tumor multiplicity (4.2 ± 0.4 vs. 2.5 ± 0.5 tumors/animal) was also observed in the caraway group compared with the control group. Together, our data show dietary caraway can significantly delay and prevent the hormonal mammary tumorigenesis by modulating different cellular and molecular targets.
Collapse
|
7
|
Greenlee H, Sardo Molmenti CL, Falci L, Ulmer R, Deming-Halverson S, DeRoo LA, Sandler DP. High use of complementary and alternative medicine among a large cohort of women with a family history of breast cancer: the Sister Study. Breast Cancer Res Treat 2016; 156:527-538. [PMID: 27017506 DOI: 10.1007/s10549-016-3740-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2016] [Accepted: 02/28/2016] [Indexed: 12/01/2022]
Abstract
Use of complementary and alternative medicine (CAM) is high among U.S. women, yet information is limited on use among women at increased breast cancer risk. We analyzed CAM use among women with a family history of breast cancer. CAM use was analyzed among women enrolled 2003-2009 in the Sister Study cohort. Eligible women were aged 35-74, U.S. or Puerto Rican residents, no personal history of breast cancer, and had ≥1 sister with breast cancer. Baseline data on CAM use in the past year were available for 49,734 women. Logistic regression models examined the association between CAM use and Gail Model breast cancer risk score. Results were compared to female participants in the 2007 National Health Interview Survey (n = 7965). Among Sister Study participants, there was high use of vitamin/mineral supplements (79 %), mind-body practices (41 %), manipulative/body-based practices (32 %), and botanicals (23 %). Overall use was higher than the U.S. female population. No association was observed between familial breast cancer risk and CAM use. Black women were more likely to use spirituality/meditation-based CAM modalities, while non-Hispanic white and Asian women were high users of dietary supplements. In a cohort of women with increased breast cancer risk due to family history, CAM use is higher than women in the general U.S. population and is associated with race/ethnicity. Use was not associated with breast cancer risk. Given the high prevalence of CAM use among women at risk for breast caner, research on the effectiveness of CAM use for disease prevention is needed.
Collapse
Affiliation(s)
- Heather Greenlee
- Mailman School of Public Health, Columbia University, 722 W. 168th Street, New York, NY, 10032, USA. .,Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.
| | - Christine L Sardo Molmenti
- Mailman School of Public Health, Columbia University, 722 W. 168th Street, New York, NY, 10032, USA.,Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
| | - Laura Falci
- Mailman School of Public Health, Columbia University, 722 W. 168th Street, New York, NY, 10032, USA
| | | | - Sandra Deming-Halverson
- Social & Scientific Systems, Inc, Durham, NC, USA.,Division of Epidemiology, Vanderbilt University School of Medicine, Nashville, TN, USA
| | - Lisa A DeRoo
- National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, USA.,Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
| | - Dale P Sandler
- National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, USA
| |
Collapse
|
8
|
Quality of Life in Women With Breast Cancer and the Use of Complementary and Alternative Medicine. Holist Nurs Pract 2014; 28:258-64. [DOI: 10.1097/hnp.0000000000000038] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|